New Insights on How Inflammatory Molecule Contributes to Skin and Pancreatic Cancers
The molecule, interleukin-33, activates signals in a cell’s nucleus to promote abnormal growth.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Our main office is conveniently located at 50 Staniford Street in Boston, near public transportation.
The Massachusetts General Hospital Department of Dermatology delivers state-of-the-art care to patients with rare and common conditions of the skin, hair and nails.
Our department's board-certified physicians have one overarching goal: helping patients enjoy their everyday activities while minimizing or eliminating their symptoms. Referring physicians also consult us to clarify challenging diagnoses.
We provide the most advanced treatments for conditions including:
Additionally, our world-class medical staff treats acute and rare diseases and disorders, such as:
Since the 1800s, we have led the way in developing new treatments for skin conditions, including:
We also opened the first multidisciplinary center for patients with cutaneous melanoma in 1966.
In the 21st century, we continue to break new ground. The Clinical Unit for Research Trials in Skin helps patients who have not responded to traditional treatments and develops novel therapies, diagnostics, clinical procedures and medications. Our Cutaneous Biology Research Center works on discovering fundamental principles and genetics that contribute to maintaining healthy skin and treating disease.
With more than 90,000 visits annually, we are trusted by patients throughout New England. In addition to our general dermatology clinics we offer the following specialty services:
Specialty treatment programs are offered at our Boston location at 50 Staniford Street. Additionally, we also general and medical dermatology services at Mass General North in Danvers and at Mass General Health Centers in Charlestown, Revere, and Chelsea.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
The molecule, interleukin-33, activates signals in a cell’s nucleus to promote abnormal growth.
Combination treatment stimulates the immune system to attack multiple proteins on tumors.
Fernanda H. Sakamoto, MD, PhD, physician-researcher in the Department of Dermatology, shares her “My Why”—outlining her decision to get the COVID-19 vaccine in Portuguese.
Not only were two MGHers honored with the annual Ernesto Gonzalez Award for Outstanding Services to the Hispanic Community, but one standout group was given the honorific name, “The Ernesto Gonzalez Service.”
Topical calcineurin inhibitors used to treat atopic dermatitis were not associated with increased risk for either basal cell or squamous cell carcinomas.
Certain skin changes may be the only sign of COVID-19 infection, or may accompany or follow other COVID-19 symptoms, an analysis of data from 716 patients in 31 countries shows.
The best times to call for appointments are Monday- Friday from 9:00am-12 noon and 1:00pm to 5:00pm. Our main office can schedule appointments for both the Boston and the Danvers locations.